Kajian klinikal Lupus di Oklahoma
8 kajian untuk Lupus sedang mencari peserta di lokasi di Oklahoma.
Bandar di Oklahoma
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50262, Oklahoma City
Mengambil pesertaFasa 3
Umur 16 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Oklahoma Medical Research Foundation, Oklahoma City
Mengambil pesertaFasa 2
Umur 18 hingga 74 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07409181A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Oklahoma City
- Research Site, Oklahoma City
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07430306A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- Oklahoma Medical Research Foundation, Oklahoma City
Mengambil pesertaFasa 4
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06875960A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Oklahoma Medical Research Foundation, Oklahoma City
Mengambil pesertaKajian pemerhatian
Umur 16 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07175285Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Oklahoma Medical Research Foundation, Oklahoma City
Mengambil pesertaFasa 3
Umur 55 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05799378A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Oklahoma, Oklahoma City
Mengambil pesertaFasa 1
Umur 12 hingga 70 · Semua jantina · Dikemas kini 22 Mei 2026 · NCT06308978Safety of the Herpes Zoster Subunit Vaccine in Lupus
- Oklahoma Medical Research Foundation, Oklahoma City
Mengambil pesertaFasa 4
Umur 18 hingga 90 · Semua jantina · Dikemas kini 26 Dis 2025 · NCT05559671Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.